

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 5.86870546 |
| 2 | lysine catabolic process (GO:0006554) | 5.86870546 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.47146240 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.47146240 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.42016991 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.42016991 |
| 7 | kynurenine metabolic process (GO:0070189) | 5.26436326 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.18666820 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.06053907 |
| 10 | 2-oxoglutarate metabolic process (GO:0006103) | 5.03372372 |
| 11 | proline biosynthetic process (GO:0006561) | 4.93637788 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 4.93132153 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82297217 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 4.77868413 |
| 15 | ribosomal small subunit biogenesis (GO:0042274) | 4.76994078 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 4.76580769 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 4.76580769 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.76580769 |
| 19 | fatty acid transmembrane transport (GO:1902001) | 4.75838196 |
| 20 | maturation of SSU-rRNA (GO:0030490) | 4.74977829 |
| 21 | carnitine shuttle (GO:0006853) | 4.73724572 |
| 22 | aspartate family amino acid catabolic process (GO:0009068) | 4.67077597 |
| 23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.64261178 |
| 24 | fatty acid beta-oxidation (GO:0006635) | 4.60592037 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.58117276 |
| 26 | amino-acid betaine metabolic process (GO:0006577) | 4.49548165 |
| 27 | acetyl-CoA metabolic process (GO:0006084) | 4.49153879 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.44470054 |
| 29 | urea cycle (GO:0000050) | 4.42771474 |
| 30 | urea metabolic process (GO:0019627) | 4.42771474 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 4.41441813 |
| 32 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.32638830 |
| 33 | bile acid biosynthetic process (GO:0006699) | 4.32457731 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.32082954 |
| 35 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.24927311 |
| 36 | glycine metabolic process (GO:0006544) | 4.22423884 |
| 37 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.17929031 |
| 38 | fatty acid oxidation (GO:0019395) | 4.17492757 |
| 39 | oxaloacetate metabolic process (GO:0006107) | 4.16349920 |
| 40 | regulation of mitochondrial translation (GO:0070129) | 4.16013628 |
| 41 | cysteine metabolic process (GO:0006534) | 4.14920736 |
| 42 | NADH metabolic process (GO:0006734) | 4.11208133 |
| 43 | fatty acid catabolic process (GO:0009062) | 4.10180427 |
| 44 | lipid oxidation (GO:0034440) | 4.10162359 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.06989070 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.06231469 |
| 47 | carnitine metabolic process (GO:0009437) | 4.01822500 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 3.99691007 |
| 49 | ethanol oxidation (GO:0006069) | 3.97237878 |
| 50 | monocarboxylic acid catabolic process (GO:0072329) | 3.94927544 |
| 51 | valine metabolic process (GO:0006573) | 3.91533183 |
| 52 | sarcomere organization (GO:0045214) | 3.91086638 |
| 53 | sulfur amino acid catabolic process (GO:0000098) | 3.90578565 |
| 54 | negative regulation of fibrinolysis (GO:0051918) | 3.88751772 |
| 55 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.84052584 |
| 56 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.81341997 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.80512222 |
| 58 | ketone body metabolic process (GO:1902224) | 3.80162945 |
| 59 | branched-chain amino acid catabolic process (GO:0009083) | 3.78329988 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 3.78164703 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.76556544 |
| 62 | tricarboxylic acid metabolic process (GO:0072350) | 3.76011165 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 3.74915412 |
| 64 | regulation of protein activation cascade (GO:2000257) | 3.74837021 |
| 65 | serine family amino acid biosynthetic process (GO:0009070) | 3.74746388 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 3.73156797 |
| 67 | complement activation, alternative pathway (GO:0006957) | 3.72353958 |
| 68 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.72338608 |
| 69 | pseudouridine synthesis (GO:0001522) | 3.72191473 |
| 70 | proline metabolic process (GO:0006560) | 3.67255127 |
| 71 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65688405 |
| 72 | carnitine transmembrane transport (GO:1902603) | 3.63218343 |
| 73 | histone arginine methylation (GO:0034969) | 3.62909245 |
| 74 | organic acid catabolic process (GO:0016054) | 3.62416201 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 3.62416201 |
| 76 | protein maturation by protein folding (GO:0022417) | 3.61264288 |
| 77 | regulation of fatty acid oxidation (GO:0046320) | 3.61252599 |
| 78 | branched-chain amino acid metabolic process (GO:0009081) | 3.58959547 |
| 79 | ribosome biogenesis (GO:0042254) | 3.57461753 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.57317303 |
| 81 | carnitine transport (GO:0015879) | 3.56437977 |
| 82 | amino-acid betaine transport (GO:0015838) | 3.56437977 |
| 83 | phospholipid homeostasis (GO:0055091) | 3.55826085 |
| 84 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.52713917 |
| 85 | protein carboxylation (GO:0018214) | 3.51601831 |
| 86 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.51601831 |
| 87 | regulation of fibrinolysis (GO:0051917) | 3.51373576 |
| 88 | regulation of complement activation (GO:0030449) | 3.50362977 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 3.49232333 |
| 90 | succinate metabolic process (GO:0006105) | 3.47863074 |
| 91 | bile acid metabolic process (GO:0008206) | 3.47640848 |
| 92 | peptidyl-arginine N-methylation (GO:0035246) | 3.47354440 |
| 93 | peptidyl-arginine methylation (GO:0018216) | 3.47354440 |
| 94 | formation of translation preinitiation complex (GO:0001731) | 3.46862620 |
| 95 | L-serine metabolic process (GO:0006563) | 3.45323760 |
| 96 | rRNA transcription (GO:0009303) | 3.44473701 |
| 97 | oxidative phosphorylation (GO:0006119) | 3.43735327 |
| 98 | glutamate metabolic process (GO:0006536) | 3.43656286 |
| 99 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.42308370 |
| 100 | tyrosine metabolic process (GO:0006570) | 3.41767565 |
| 101 | regulation of translational fidelity (GO:0006450) | 3.41403489 |
| 102 | acylglycerol homeostasis (GO:0055090) | 3.40536603 |
| 103 | triglyceride homeostasis (GO:0070328) | 3.40536603 |
| 104 | fatty acid homeostasis (GO:0055089) | 3.40294855 |
| 105 | biotin metabolic process (GO:0006768) | 3.39277375 |
| 106 | UTP biosynthetic process (GO:0006228) | 3.38432055 |
| 107 | coenzyme catabolic process (GO:0009109) | 3.36841283 |
| 108 | mitochondrial fusion (GO:0008053) | 3.34418066 |
| 109 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34359197 |
| 110 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.32125857 |
| 111 | proteasome assembly (GO:0043248) | 3.31535349 |
| 112 | plasma lipoprotein particle clearance (GO:0034381) | 3.31039672 |
| 113 | plasma lipoprotein particle remodeling (GO:0034369) | 3.30668733 |
| 114 | protein-lipid complex remodeling (GO:0034368) | 3.30668733 |
| 115 | macromolecular complex remodeling (GO:0034367) | 3.30668733 |
| 116 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.29873918 |
| 117 | actin-myosin filament sliding (GO:0033275) | 3.28553207 |
| 118 | muscle filament sliding (GO:0030049) | 3.28553207 |
| 119 | positive regulation of lipid catabolic process (GO:0050996) | 3.28292000 |
| 120 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26972134 |
| 121 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.26961051 |
| 122 | indolalkylamine metabolic process (GO:0006586) | 3.25943192 |
| 123 | positive regulation of fatty acid oxidation (GO:0046321) | 3.25824548 |
| 124 | regulation of cholesterol esterification (GO:0010872) | 3.23693227 |
| 125 | negative regulation of cholesterol transport (GO:0032375) | 3.23534149 |
| 126 | mitotic nuclear envelope reassembly (GO:0007084) | 3.23505974 |
| 127 | nuclear envelope reassembly (GO:0031468) | 3.23505974 |
| 128 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.22924970 |
| 129 | DNA strand elongation (GO:0022616) | 3.21469443 |
| 130 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.20630367 |
| 131 | DNA unwinding involved in DNA replication (GO:0006268) | 3.20106715 |
| 132 | GDP-mannose metabolic process (GO:0019673) | 3.18950709 |
| 133 | GTP biosynthetic process (GO:0006183) | 3.18704621 |
| 134 | UTP metabolic process (GO:0046051) | 3.17952356 |
| 135 | tRNA methylation (GO:0030488) | 3.16921927 |
| 136 | protein targeting to mitochondrion (GO:0006626) | 3.16537107 |
| 137 | regulation of translational termination (GO:0006449) | 3.15365864 |
| 138 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.13915128 |
| 139 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.12422666 |
| 140 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.08760044 |
| 141 | spliceosomal snRNP assembly (GO:0000387) | 3.07399155 |
| 142 | gluconeogenesis (GO:0006094) | 3.03056010 |
| 143 | establishment of protein localization to mitochondrion (GO:0072655) | 3.02723616 |
| 144 | cellular component biogenesis (GO:0044085) | 2.99758840 |
| 145 | transcription from mitochondrial promoter (GO:0006390) | 2.97761583 |
| 146 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.97165143 |
| 147 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.97121438 |
| 148 | viral transcription (GO:0019083) | 2.96995605 |
| 149 | mitochondrial RNA metabolic process (GO:0000959) | 2.96287856 |
| 150 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.96220285 |
| 151 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.95231424 |
| 152 | monosaccharide biosynthetic process (GO:0046364) | 2.94989842 |
| 153 | viral mRNA export from host cell nucleus (GO:0046784) | 2.94878456 |
| 154 | CTP metabolic process (GO:0046036) | 2.93089384 |
| 155 | CTP biosynthetic process (GO:0006241) | 2.93089384 |
| 156 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.91982505 |
| 157 | rRNA processing (GO:0006364) | 2.91486355 |
| 158 | folic acid metabolic process (GO:0046655) | 2.88896508 |
| 159 | hexose biosynthetic process (GO:0019319) | 2.87872903 |
| 160 | DNA replication checkpoint (GO:0000076) | 2.86908936 |
| 161 | protein localization to mitochondrion (GO:0070585) | 2.86534790 |
| 162 | translational elongation (GO:0006414) | 2.85863169 |
| 163 | mitotic chromosome condensation (GO:0007076) | 2.85709987 |
| 164 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.82599665 |
| 165 | pentose metabolic process (GO:0019321) | 2.80836918 |
| 166 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.80413488 |
| 167 | translational termination (GO:0006415) | 2.79437951 |
| 168 | ribosome assembly (GO:0042255) | 2.76521236 |
| 169 | rRNA metabolic process (GO:0016072) | 2.73557556 |
| 170 | rRNA modification (GO:0000154) | 2.72748766 |
| 171 | translation (GO:0006412) | 2.72037541 |
| 172 | establishment of integrated proviral latency (GO:0075713) | 2.70608099 |
| 173 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.69450981 |
| 174 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.69091112 |
| 175 | Golgi transport vesicle coating (GO:0048200) | 2.66541464 |
| 176 | COPI coating of Golgi vesicle (GO:0048205) | 2.66541464 |
| 177 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.66189549 |
| 178 | negative regulation of ligase activity (GO:0051352) | 2.65993223 |
| 179 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.65993223 |
| 180 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.64642205 |
| 181 | IMP biosynthetic process (GO:0006188) | 2.63501989 |
| 182 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.62033011 |
| 183 | purine nucleobase biosynthetic process (GO:0009113) | 2.61941551 |
| 184 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.61239200 |
| 185 | tRNA modification (GO:0006400) | 2.61162375 |
| 186 | nucleobase biosynthetic process (GO:0046112) | 2.61034154 |
| 187 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.59287692 |
| 188 | ribosomal large subunit biogenesis (GO:0042273) | 2.59075699 |
| 189 | pentose-phosphate shunt (GO:0006098) | 2.58878173 |
| 190 | iron-sulfur cluster assembly (GO:0016226) | 2.58693147 |
| 191 | metallo-sulfur cluster assembly (GO:0031163) | 2.58693147 |
| 192 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.58157299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.29512353 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.70932857 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09646095 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.73844880 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.69022806 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.32082818 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.65174845 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.62743109 |
| 9 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.61019553 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.54291467 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.29504530 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.78190597 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.53369258 |
| 14 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.52894822 |
| 15 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.50977927 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.45259260 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.32467707 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21892238 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18542226 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.16717952 |
| 21 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.16285074 |
| 22 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.08775619 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08552455 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.06942914 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01223772 |
| 26 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96396507 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92021161 |
| 28 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.90519450 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85501281 |
| 30 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.74180142 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72938642 |
| 32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.72869469 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.70192931 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.67546822 |
| 35 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.64663677 |
| 36 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.64347386 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.59636787 |
| 38 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.59241562 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.57943652 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57686249 |
| 41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.57504394 |
| 42 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57347875 |
| 43 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.52916388 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52587792 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51175021 |
| 46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.47409433 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.46569771 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.46569771 |
| 49 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.45411269 |
| 50 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.36564523 |
| 51 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35218461 |
| 52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34953274 |
| 53 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.34818945 |
| 54 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.34468286 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31998767 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30047772 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.29622117 |
| 58 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28982795 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28888084 |
| 60 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27222643 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25932226 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23806481 |
| 63 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23653873 |
| 64 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.21425668 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20684035 |
| 66 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.19167294 |
| 67 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18566018 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18333205 |
| 69 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18304260 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17640936 |
| 71 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17405725 |
| 72 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.16887398 |
| 73 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.16694597 |
| 74 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15929117 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14817334 |
| 76 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.13306161 |
| 77 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.12844075 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12589813 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12365315 |
| 80 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12197893 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11841928 |
| 82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11815947 |
| 83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11508284 |
| 84 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10977377 |
| 85 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09320752 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09116902 |
| 87 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07301831 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06825485 |
| 89 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06515203 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04632313 |
| 91 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04627126 |
| 92 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01383416 |
| 93 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00714098 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98356934 |
| 95 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98054957 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96730305 |
| 97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96412608 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95776339 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95522233 |
| 100 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94350798 |
| 101 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.94270864 |
| 102 | MYC_22102868_ChIP-Seq_BL_Human | 0.93784677 |
| 103 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.91393475 |
| 104 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.84896025 |
| 105 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83426530 |
| 106 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.83271803 |
| 107 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.81835326 |
| 108 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.81821186 |
| 109 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.81760749 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80554368 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80286237 |
| 112 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.79791089 |
| 113 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79734720 |
| 114 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.78908378 |
| 115 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78647455 |
| 116 | ATF3_27146783_Chip-Seq_COLON_Human | 0.78639483 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.76572563 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76301980 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75331116 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75309426 |
| 121 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.73622170 |
| 122 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72330779 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72319569 |
| 124 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.70384406 |
| 125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69762720 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68816807 |
| 127 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68671764 |
| 128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67883455 |
| 129 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.67450001 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66334291 |
| 131 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.66223592 |
| 132 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.66135262 |
| 133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65938605 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65433975 |
| 135 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.64666449 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 0.64356709 |
| 137 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.63863769 |
| 138 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.63136460 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.63129914 |
| 140 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.63079545 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63067413 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62551788 |
| 143 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.62206154 |
| 144 | MAF_26560356_Chip-Seq_TH1_Human | 0.61990573 |
| 145 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.61866811 |
| 146 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.60994637 |
| 147 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.59904780 |
| 148 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59895643 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.59697268 |
| 150 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.59261958 |
| 151 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59251950 |
| 152 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.59052677 |
| 153 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.59052000 |
| 154 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59010322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.72110182 |
| 2 | MP0005360_urolithiasis | 5.63599975 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.58210490 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.25963106 |
| 5 | MP0005365_abnormal_bile_salt | 4.25543616 |
| 6 | MP0003693_abnormal_embryo_hatching | 4.23940841 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 4.19143694 |
| 8 | MP0003646_muscle_fatigue | 3.65289018 |
| 9 | MP0003111_abnormal_nucleus_morphology | 3.28980738 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.14577190 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.94735766 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.75796315 |
| 13 | MP0003252_abnormal_bile_duct | 2.71738384 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.56319509 |
| 15 | MP0009840_abnormal_foam_cell | 2.52519718 |
| 16 | MP0005332_abnormal_amino_acid | 2.48366086 |
| 17 | MP0000751_myopathy | 2.47345121 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.41459220 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.39678201 |
| 20 | MP0005330_cardiomyopathy | 2.33384320 |
| 21 | MP0000749_muscle_degeneration | 2.31839116 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.30074993 |
| 23 | MP0004130_abnormal_muscle_cell | 2.27858930 |
| 24 | MP0005083_abnormal_biliary_tract | 2.24689452 |
| 25 | MP0003077_abnormal_cell_cycle | 2.20596912 |
| 26 | MP0004215_abnormal_myocardial_fiber | 2.17324962 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 2.16388935 |
| 28 | MP0008058_abnormal_DNA_repair | 2.07812970 |
| 29 | MP0008932_abnormal_embryonic_tissue | 2.06668002 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.95055743 |
| 31 | MP0003195_calcinosis | 1.90504853 |
| 32 | MP0004087_abnormal_muscle_fiber | 1.89300689 |
| 33 | MP0008260_abnormal_autophagy | 1.89054092 |
| 34 | MP0002269_muscular_atrophy | 1.85256914 |
| 35 | MP0000609_abnormal_liver_physiology | 1.79076723 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.78966676 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.78122962 |
| 38 | MP0003786_premature_aging | 1.75304865 |
| 39 | MP0001661_extended_life_span | 1.75046527 |
| 40 | MP0005501_abnormal_skin_physiology | 1.73892242 |
| 41 | MP0005670_abnormal_white_adipose | 1.68148904 |
| 42 | MP0002653_abnormal_ependyma_morphology | 1.67050064 |
| 43 | MP0004858_abnormal_nervous_system | 1.66710272 |
| 44 | MP0002118_abnormal_lipid_homeostasis | 1.64605172 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.61052128 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.60538814 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.56186715 |
| 48 | MP0001730_embryonic_growth_arrest | 1.55889563 |
| 49 | MP0008775_abnormal_heart_ventricle | 1.55720147 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.55417129 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.54709496 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.53879733 |
| 53 | MP0002163_abnormal_gland_morphology | 1.51782306 |
| 54 | MP0002972_abnormal_cardiac_muscle | 1.51202427 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49571074 |
| 56 | MP0001544_abnormal_cardiovascular_syste | 1.47165645 |
| 57 | MP0005385_cardiovascular_system_phenoty | 1.47165645 |
| 58 | MP0000747_muscle_weakness | 1.44661840 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44355280 |
| 60 | MP0001727_abnormal_embryo_implantation | 1.44028964 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.43996004 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.41271156 |
| 63 | MP0002796_impaired_skin_barrier | 1.41114140 |
| 64 | MP0005620_abnormal_muscle_contractility | 1.40645539 |
| 65 | MP0002106_abnormal_muscle_physiology | 1.34919798 |
| 66 | MP0000750_abnormal_muscle_regeneration | 1.31768090 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.31587245 |
| 68 | MP0003137_abnormal_impulse_conducting | 1.31384196 |
| 69 | MP0000350_abnormal_cell_proliferation | 1.31300135 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.28467819 |
| 71 | MP0004147_increased_porphyrin_level | 1.24655871 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.24293443 |
| 73 | MP0003186_abnormal_redox_activity | 1.23917401 |
| 74 | MP0001764_abnormal_homeostasis | 1.21555659 |
| 75 | MP0005623_abnormal_meninges_morphology | 1.16199959 |
| 76 | MP0009643_abnormal_urine_homeostasis | 1.16007653 |
| 77 | MP0006138_congestive_heart_failure | 1.14904200 |
| 78 | MP0010030_abnormal_orbit_morphology | 1.14759163 |
| 79 | MP0005266_abnormal_metabolism | 1.13885178 |
| 80 | MP0002080_prenatal_lethality | 1.13564839 |
| 81 | MP0000313_abnormal_cell_death | 1.12136298 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.11989353 |
| 83 | MP0003315_abnormal_perineum_morphology | 1.11707293 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 1.11654307 |
| 85 | MP0000759_abnormal_skeletal_muscle | 1.11182920 |
| 86 | MP0003718_maternal_effect | 1.08731741 |
| 87 | MP0000598_abnormal_liver_morphology | 1.03920377 |
| 88 | MP0005451_abnormal_body_composition | 1.03005000 |
| 89 | MP0001881_abnormal_mammary_gland | 1.03001579 |
| 90 | MP0005369_muscle_phenotype | 1.02256965 |
| 91 | MP0002971_abnormal_brown_adipose | 1.01398184 |
| 92 | MP0001697_abnormal_embryo_size | 0.98313505 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.96435416 |
| 94 | MP0003123_paternal_imprinting | 0.96195277 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.95690379 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.94206480 |
| 97 | MP0001672_abnormal_embryogenesis/_devel | 0.92467727 |
| 98 | MP0005380_embryogenesis_phenotype | 0.92467727 |
| 99 | MP0009697_abnormal_copulation | 0.91019383 |
| 100 | MP0009379_abnormal_foot_pigmentation | 0.90652119 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.89972957 |
| 102 | MP0009053_abnormal_anal_canal | 0.89414828 |
| 103 | MP0004484_altered_response_of | 0.89276006 |
| 104 | MP0004233_abnormal_muscle_weight | 0.86767499 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.86675402 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.86613183 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.84568547 |
| 108 | MP0003984_embryonic_growth_retardation | 0.82931470 |
| 109 | MP0001873_stomach_inflammation | 0.81704405 |
| 110 | MP0003136_yellow_coat_color | 0.81534203 |
| 111 | MP0002249_abnormal_larynx_morphology | 0.79048139 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.78383666 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77996399 |
| 114 | MP0001853_heart_inflammation | 0.77860725 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 0.77695306 |
| 116 | MP0000733_abnormal_muscle_development | 0.77448373 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.76608301 |
| 118 | MP0002088_abnormal_embryonic_growth/wei | 0.76096312 |
| 119 | MP0009763_increased_sensitivity_to | 0.74302398 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.72055596 |
| 121 | MP0002234_abnormal_pharynx_morphology | 0.69887459 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.69727082 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.69058644 |
| 124 | MP0002127_abnormal_cardiovascular_syste | 0.68037589 |
| 125 | MP0001529_abnormal_vocalization | 0.68026974 |
| 126 | MP0005334_abnormal_fat_pad | 0.68021231 |
| 127 | MP0008469_abnormal_protein_level | 0.67192094 |
| 128 | MP0002160_abnormal_reproductive_system | 0.66652549 |
| 129 | MP0004085_abnormal_heartbeat | 0.65893625 |
| 130 | MP0002085_abnormal_embryonic_tissue | 0.65495160 |
| 131 | MP0002822_catalepsy | 0.64512099 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.64050559 |
| 133 | MP0003828_pulmonary_edema | 0.64003410 |
| 134 | MP0000266_abnormal_heart_morphology | 0.63724237 |
| 135 | MP0005535_abnormal_body_temperature | 0.63518856 |
| 136 | MP0003941_abnormal_skin_development | 0.62972730 |
| 137 | MP0005636_abnormal_mineral_homeostasis | 0.62820746 |
| 138 | MP0000490_abnormal_crypts_of | 0.62438442 |
| 139 | MP0003868_abnormal_feces_composition | 0.62425105 |
| 140 | MP0001756_abnormal_urination | 0.61043849 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.60622945 |
| 142 | MP0003011_delayed_dark_adaptation | 0.59004297 |
| 143 | MP0000343_altered_response_to | 0.57262549 |
| 144 | MP0002970_abnormal_white_adipose | 0.55988313 |
| 145 | MP0004510_myositis | 0.55483727 |
| 146 | MP0000604_amyloidosis | 0.55344393 |
| 147 | MP0009764_decreased_sensitivity_to | 0.54441172 |
| 148 | MP0009672_abnormal_birth_weight | 0.52683171 |
| 149 | MP0002128_abnormal_blood_circulation | 0.51216596 |
| 150 | MP0009115_abnormal_fat_cell | 0.47606095 |
| 151 | MP0000230_abnormal_systemic_arterial | 0.46803453 |
| 152 | MP0000249_abnormal_blood_vessel | 0.42929402 |
| 153 | MP0000358_abnormal_cell_content/ | 0.42671043 |
| 154 | MP0005165_increased_susceptibility_to | 0.42155101 |
| 155 | MP0004043_abnormal_pH_regulation | 0.41303426 |
| 156 | MP0003566_abnormal_cell_adhesion | 0.40109666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperammonemia (HP:0001987) | 4.50562571 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.49036275 |
| 3 | Myoglobinuria (HP:0002913) | 4.47935276 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.39139231 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.32255446 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.29895236 |
| 7 | Progressive muscle weakness (HP:0003323) | 4.26315285 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 4.21901765 |
| 9 | Hyperglycinuria (HP:0003108) | 4.19332802 |
| 10 | Ketosis (HP:0001946) | 4.11284624 |
| 11 | Xanthomatosis (HP:0000991) | 4.10335006 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.07837820 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.05625789 |
| 14 | Exercise-induced myalgia (HP:0003738) | 4.01153856 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.00889484 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.91984870 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91984870 |
| 18 | Ketoacidosis (HP:0001993) | 3.83752277 |
| 19 | Rhabdomyolysis (HP:0003201) | 3.82531545 |
| 20 | Sudden death (HP:0001699) | 3.82054194 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.72574988 |
| 22 | Hyperglycinemia (HP:0002154) | 3.66458415 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.62015379 |
| 24 | Abnormality of glycolysis (HP:0004366) | 3.56099740 |
| 25 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.52419681 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.48698670 |
| 27 | Hypokinesia (HP:0002375) | 3.45715113 |
| 28 | Increased serum pyruvate (HP:0003542) | 3.43197907 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 3.40576421 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.40576421 |
| 31 | Microretrognathia (HP:0000308) | 3.39247981 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 3.39167207 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.38556603 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 3.31199311 |
| 35 | Ventricular tachycardia (HP:0004756) | 3.31064623 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.25961044 |
| 37 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.22333359 |
| 38 | Complement deficiency (HP:0004431) | 3.15394192 |
| 39 | Acute necrotizing encephalopathy (HP:0006965) | 3.11013767 |
| 40 | Cerebral edema (HP:0002181) | 3.08172938 |
| 41 | Muscle fiber splitting (HP:0003555) | 3.02238623 |
| 42 | Microvesicular hepatic steatosis (HP:0001414) | 3.01631566 |
| 43 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.98630964 |
| 44 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.98630964 |
| 45 | Achilles tendon contracture (HP:0001771) | 2.95327534 |
| 46 | Hepatic necrosis (HP:0002605) | 2.93617392 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.92365559 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91409296 |
| 49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.89100212 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.85242558 |
| 51 | Metabolic acidosis (HP:0001942) | 2.82718226 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.81987753 |
| 53 | * Increased intramyocellular lipid droplets (HP:0012240) | 2.79255107 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79003292 |
| 55 | Nemaline bodies (HP:0003798) | 2.78635357 |
| 56 | Lethargy (HP:0001254) | 2.77194859 |
| 57 | Abnormality of complement system (HP:0005339) | 2.76484691 |
| 58 | Abnormality of the Achilles tendon (HP:0005109) | 2.75727098 |
| 59 | Lipoatrophy (HP:0100578) | 2.74669197 |
| 60 | Palpitations (HP:0001962) | 2.73869347 |
| 61 | * Increased CSF lactate (HP:0002490) | 2.73557822 |
| 62 | Abnormality of methionine metabolism (HP:0010901) | 2.73287095 |
| 63 | Cholelithiasis (HP:0001081) | 2.72537163 |
| 64 | Epidermoid cyst (HP:0200040) | 2.72320657 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.70831387 |
| 66 | * Increased serum lactate (HP:0002151) | 2.69544554 |
| 67 | Right ventricular cardiomyopathy (HP:0011663) | 2.66683748 |
| 68 | * Mitochondrial inheritance (HP:0001427) | 2.64955990 |
| 69 | * Exercise intolerance (HP:0003546) | 2.61300221 |
| 70 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.61270656 |
| 71 | Increased connective tissue (HP:0009025) | 2.60530452 |
| 72 | Opisthotonus (HP:0002179) | 2.60459022 |
| 73 | Hyperbilirubinemia (HP:0002904) | 2.60360354 |
| 74 | Myopathic facies (HP:0002058) | 2.59996320 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.52130172 |
| 76 | Abnormal number of erythroid precursors (HP:0012131) | 2.52126224 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.52084723 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 2.51903544 |
| 79 | Gout (HP:0001997) | 2.50692553 |
| 80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48058226 |
| 81 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.46288205 |
| 82 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.45394531 |
| 83 | Subaortic stenosis (HP:0001682) | 2.45394531 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.43527662 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 2.42975889 |
| 86 | EMG: myopathic abnormalities (HP:0003458) | 2.41001174 |
| 87 | Reticulocytopenia (HP:0001896) | 2.40579232 |
| 88 | Trismus (HP:0000211) | 2.40075452 |
| 89 | Dilated cardiomyopathy (HP:0001644) | 2.39195672 |
| 90 | Conjugated hyperbilirubinemia (HP:0002908) | 2.37211416 |
| 91 | Difficulty running (HP:0009046) | 2.34869900 |
| 92 | Atrial fibrillation (HP:0005110) | 2.34662880 |
| 93 | Abnormality of the calf musculature (HP:0001430) | 2.32584277 |
| 94 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30586606 |
| 95 | Atrioventricular block (HP:0001678) | 2.29695509 |
| 96 | Testicular atrophy (HP:0000029) | 2.29613196 |
| 97 | Joint hemorrhage (HP:0005261) | 2.29469563 |
| 98 | Ragged-red muscle fibers (HP:0003200) | 2.28170194 |
| 99 | Skin nodule (HP:0200036) | 2.26485059 |
| 100 | Abnormality of purine metabolism (HP:0004352) | 2.25789847 |
| 101 | Muscle stiffness (HP:0003552) | 2.25636704 |
| 102 | Acute encephalopathy (HP:0006846) | 2.25613480 |
| 103 | Fat malabsorption (HP:0002630) | 2.24628407 |
| 104 | Athetosis (HP:0002305) | 2.24380862 |
| 105 | Hepatocellular necrosis (HP:0001404) | 2.22357105 |
| 106 | Abnormality of reticulocytes (HP:0004312) | 2.21844092 |
| 107 | Septate vagina (HP:0001153) | 2.18194046 |
| 108 | Vomiting (HP:0002013) | 2.17291817 |
| 109 | Nausea (HP:0002018) | 2.17071328 |
| 110 | Distal lower limb muscle weakness (HP:0009053) | 2.15575243 |
| 111 | * Increased muscle lipid content (HP:0009058) | 2.15478273 |
| 112 | Primary atrial arrhythmia (HP:0001692) | 2.15342170 |
| 113 | Type I transferrin isoform profile (HP:0003642) | 2.13867168 |
| 114 | Hypercholesterolemia (HP:0003124) | 2.13492517 |
| 115 | Progressive external ophthalmoplegia (HP:0000590) | 2.13296401 |
| 116 | Reticulocytosis (HP:0001923) | 2.12969553 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.12131978 |
| 118 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12094985 |
| 119 | Abnormality of the umbilical cord (HP:0010881) | 2.11282239 |
| 120 | Late onset (HP:0003584) | 2.11234498 |
| 121 | * Lactic acidosis (HP:0003128) | 2.10981999 |
| 122 | Supraventricular tachycardia (HP:0004755) | 2.10374754 |
| 123 | Neonatal death (HP:0003811) | 2.09918326 |
| 124 | Prolonged neonatal jaundice (HP:0006579) | 2.09069821 |
| 125 | Hyperthyroidism (HP:0000836) | 2.08292528 |
| 126 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08044333 |
| 127 | Muscle fiber inclusion bodies (HP:0100299) | 2.06516208 |
| 128 | Abnormality of the tricuspid valve (HP:0001702) | 2.06160335 |
| 129 | Supraventricular arrhythmia (HP:0005115) | 2.05562199 |
| 130 | Progressive macrocephaly (HP:0004481) | 2.04846127 |
| 131 | Birth length less than 3rd percentile (HP:0003561) | 2.04620348 |
| 132 | Hypoglycemic seizures (HP:0002173) | 2.04076703 |
| 133 | * Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.03771482 |
| 134 | Hypertensive crisis (HP:0100735) | 2.03330312 |
| 135 | Increased purine levels (HP:0004368) | 2.01792031 |
| 136 | Hyperuricemia (HP:0002149) | 2.01792031 |
| 137 | Rough bone trabeculation (HP:0100670) | 2.01749782 |
| 138 | Ulnar deviation of the wrist (HP:0003049) | 2.00822929 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 2.00551597 |
| 140 | Cholecystitis (HP:0001082) | 2.00551597 |
| 141 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.99264629 |
| 142 | Bundle branch block (HP:0011710) | 1.98854600 |
| 143 | Unilateral renal agenesis (HP:0000122) | 1.97584248 |
| 144 | Multiple enchondromatosis (HP:0005701) | 1.97554853 |
| 145 | Broad distal phalanx of finger (HP:0009836) | 1.94949191 |
| 146 | Macrocytic anemia (HP:0001972) | 1.94801272 |
| 147 | Hyperalaninemia (HP:0003348) | 1.94413600 |
| 148 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94413600 |
| 149 | Abnormality of alanine metabolism (HP:0010916) | 1.94413600 |
| 150 | Reduced antithrombin III activity (HP:0001976) | 1.93211574 |
| 151 | Respiratory failure (HP:0002878) | 1.91646800 |
| 152 | Shoulder girdle muscle weakness (HP:0003547) | 1.85738933 |
| 153 | Entropion (HP:0000621) | 1.85677968 |
| 154 | Abnormal protein glycosylation (HP:0012346) | 1.84859185 |
| 155 | Abnormal glycosylation (HP:0012345) | 1.84859185 |
| 156 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84859185 |
| 157 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84859185 |
| 158 | Progressive microcephaly (HP:0000253) | 1.84710333 |
| 159 | Hypoplastic left heart (HP:0004383) | 1.79062660 |
| 160 | Back pain (HP:0003418) | 1.77052939 |
| 161 | Truncus arteriosus (HP:0001660) | 1.74665094 |
| 162 | Spastic diplegia (HP:0001264) | 1.74332634 |
| 163 | Abnormality of the gallbladder (HP:0005264) | 1.71828484 |
| 164 | Microglossia (HP:0000171) | 1.71270129 |
| 165 | Breast hypoplasia (HP:0003187) | 1.70642923 |
| 166 | Seborrheic dermatitis (HP:0001051) | 1.70031553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.20522118 |
| 2 | TTN | 4.28698128 |
| 3 | PKN2 | 4.08663816 |
| 4 | OBSCN | 3.56733324 |
| 5 | VRK2 | 3.48683998 |
| 6 | TRIB3 | 3.47211028 |
| 7 | PDK4 | 3.24970166 |
| 8 | PDK3 | 3.24970166 |
| 9 | NEK1 | 3.16897015 |
| 10 | IRAK3 | 3.09434187 |
| 11 | PIM2 | 3.00775456 |
| 12 | SMG1 | 2.84717920 |
| 13 | LMTK2 | 2.68534529 |
| 14 | STK16 | 2.39938797 |
| 15 | SIK1 | 2.29322129 |
| 16 | FGFR4 | 2.17145578 |
| 17 | PHKG1 | 2.12981833 |
| 18 | PHKG2 | 2.12981833 |
| 19 | FLT3 | 1.99654657 |
| 20 | PDK2 | 1.97008240 |
| 21 | ERN1 | 1.88172808 |
| 22 | ARAF | 1.85081381 |
| 23 | MAP2K3 | 1.84275113 |
| 24 | NEK9 | 1.81497282 |
| 25 | PBK | 1.79528716 |
| 26 | CDC7 | 1.77447180 |
| 27 | MYLK | 1.76457819 |
| 28 | EPHA2 | 1.73582390 |
| 29 | BUB1 | 1.60420419 |
| 30 | MAP3K10 | 1.56022141 |
| 31 | MAP3K7 | 1.55222444 |
| 32 | ICK | 1.52964323 |
| 33 | AURKA | 1.43667875 |
| 34 | TESK2 | 1.40869606 |
| 35 | NME1 | 1.40574025 |
| 36 | CDK8 | 1.37181464 |
| 37 | FGFR3 | 1.34205822 |
| 38 | TESK1 | 1.22720318 |
| 39 | MAPK11 | 1.20151668 |
| 40 | TAF1 | 1.16254161 |
| 41 | CSNK1G3 | 1.14082336 |
| 42 | CHEK2 | 1.12739253 |
| 43 | TYK2 | 1.11499482 |
| 44 | SRPK1 | 1.08974664 |
| 45 | STK4 | 1.08604890 |
| 46 | PINK1 | 1.05748463 |
| 47 | MAPK12 | 1.05349864 |
| 48 | CDK7 | 1.04963649 |
| 49 | MAP4K1 | 1.04441706 |
| 50 | BRSK1 | 1.02783553 |
| 51 | PTK6 | 1.01597706 |
| 52 | PAK4 | 1.00828541 |
| 53 | MAPKAPK5 | 1.00614741 |
| 54 | CAMK2G | 0.99581070 |
| 55 | BRAF | 0.98718495 |
| 56 | EEF2K | 0.98606495 |
| 57 | PRKD3 | 0.95363539 |
| 58 | TAOK2 | 0.94540900 |
| 59 | PIK3CG | 0.94493099 |
| 60 | MAP3K5 | 0.93426451 |
| 61 | PIK3CA | 0.93321434 |
| 62 | MAP2K2 | 0.91573569 |
| 63 | LIMK1 | 0.90561708 |
| 64 | MUSK | 0.89578817 |
| 65 | PRKAA1 | 0.89413324 |
| 66 | MAP3K3 | 0.89021356 |
| 67 | DMPK | 0.88053005 |
| 68 | INSRR | 0.88010966 |
| 69 | STK24 | 0.79822489 |
| 70 | MAP2K7 | 0.79224766 |
| 71 | EIF2AK1 | 0.79100279 |
| 72 | PRKAA2 | 0.78919953 |
| 73 | VRK1 | 0.78615143 |
| 74 | TSSK6 | 0.76992873 |
| 75 | MAP2K4 | 0.75237068 |
| 76 | MAP3K11 | 0.74748032 |
| 77 | PRKCI | 0.74291685 |
| 78 | TGFBR2 | 0.74275724 |
| 79 | CDK4 | 0.71278769 |
| 80 | PRPF4B | 0.70161126 |
| 81 | ZAK | 0.69055519 |
| 82 | FGFR1 | 0.68594291 |
| 83 | CAMK2D | 0.66967472 |
| 84 | TLK1 | 0.66781006 |
| 85 | TIE1 | 0.66379285 |
| 86 | CSNK1G2 | 0.65526686 |
| 87 | KDR | 0.64992827 |
| 88 | ILK | 0.63873705 |
| 89 | GRK6 | 0.63616090 |
| 90 | JAK2 | 0.61867495 |
| 91 | NME2 | 0.61792311 |
| 92 | CSNK1G1 | 0.61562937 |
| 93 | CSNK1A1L | 0.60614853 |
| 94 | ATR | 0.60505318 |
| 95 | RPS6KA5 | 0.60071969 |
| 96 | CSF1R | 0.59887949 |
| 97 | ABL2 | 0.57844690 |
| 98 | DYRK3 | 0.57755753 |
| 99 | CAMK2B | 0.57447733 |
| 100 | PDGFRA | 0.56769146 |
| 101 | CHEK1 | 0.56561167 |
| 102 | JAK1 | 0.55578799 |
| 103 | MAP3K8 | 0.55134216 |
| 104 | MST1R | 0.54625020 |
| 105 | STK38L | 0.54191366 |
| 106 | AKT2 | 0.53072570 |
| 107 | SIK3 | 0.52709731 |
| 108 | PRKD1 | 0.52382356 |
| 109 | CCNB1 | 0.52261019 |
| 110 | STK10 | 0.51640108 |
| 111 | RPS6KA4 | 0.50508153 |
| 112 | PRKACG | 0.50060326 |
| 113 | PDK1 | 0.48333186 |
| 114 | PDPK1 | 0.48331914 |
| 115 | ERBB4 | 0.48093309 |
| 116 | DAPK1 | 0.47283179 |
| 117 | TTK | 0.47006435 |
| 118 | CDK9 | 0.46567797 |
| 119 | CSNK2A2 | 0.46496578 |
| 120 | GRK7 | 0.45860219 |
| 121 | CSNK2A1 | 0.45835419 |
| 122 | MTOR | 0.44558364 |
| 123 | LRRK2 | 0.43106320 |
| 124 | TAOK3 | 0.42825983 |
| 125 | MELK | 0.41722624 |
| 126 | RAF1 | 0.40885575 |
| 127 | MAP2K6 | 0.40129353 |
| 128 | CDK6 | 0.40082345 |
| 129 | MAPKAPK3 | 0.39949964 |
| 130 | CDK11A | 0.39769390 |
| 131 | TBK1 | 0.39759270 |
| 132 | WEE1 | 0.39081732 |
| 133 | PAK1 | 0.38916383 |
| 134 | CDK14 | 0.38847282 |
| 135 | MAPKAPK2 | 0.38744085 |
| 136 | MAPK4 | 0.37573530 |
| 137 | ROCK1 | 0.36622197 |
| 138 | DYRK1B | 0.35207900 |
| 139 | PKN1 | 0.34842843 |
| 140 | CSK | 0.34784576 |
| 141 | MET | 0.34544397 |
| 142 | SCYL2 | 0.34506406 |
| 143 | DAPK3 | 0.33993972 |
| 144 | RPS6KB2 | 0.31482233 |
| 145 | SGK3 | 0.30658509 |
| 146 | RPS6KA6 | 0.29712251 |
| 147 | RPS6KC1 | 0.29492077 |
| 148 | RPS6KL1 | 0.29492077 |
| 149 | PRKACB | 0.27729968 |
| 150 | ITK | 0.23014970 |
| 151 | PAK3 | 0.22699071 |
| 152 | ALK | 0.22574008 |
| 153 | CDK12 | 0.22162861 |
| 154 | AURKB | 0.22095227 |
| 155 | WNK4 | 0.21805540 |
| 156 | PRKCQ | 0.21769651 |
| 157 | RET | 0.21318645 |
| 158 | LATS2 | 0.20879067 |
| 159 | PLK1 | 0.20850261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.08250078 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.39208405 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.30903677 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.29976342 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22530632 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.09308813 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.98083760 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.96791446 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.93954537 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76580465 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69195933 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.50469522 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48504777 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47337657 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.27682378 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23694244 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 2.23363208 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.19247180 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13771516 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.12382162 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.03516450 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93288148 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.84435617 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.83718080 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.82464052 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.80785388 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76998817 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75011895 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.71680216 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69515225 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62332389 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54247196 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53964866 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52529565 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50876554 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47413260 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.43279783 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.37703978 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32372994 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.32056100 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.28478638 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.22445427 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21169678 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18792252 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17097406 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15395718 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15331957 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10808967 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09303888 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.06427051 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06102519 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05145534 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.05087987 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03047770 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00548259 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00244082 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97817503 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95931266 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95156203 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94462035 |
| 61 | Cell cycle_Homo sapiens_hsa04110 | 0.92532389 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91933141 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.87101371 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86547825 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85464004 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84785217 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83821016 |
| 68 | Purine metabolism_Homo sapiens_hsa00230 | 0.83113826 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81490285 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79491751 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.79063544 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77573776 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.77289094 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77024256 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75921103 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74717406 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72913730 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69610197 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68489904 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67989450 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67292657 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64505680 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.62861619 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61189443 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59374636 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59077179 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57697983 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57472240 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55393280 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53596952 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53461897 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52030203 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49160432 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48796501 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48475642 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47668849 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46102953 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40921554 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40460362 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.37525988 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37143291 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35945648 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34309318 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33063154 |
| 105 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31878127 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31579621 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31378639 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31207106 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31010024 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30210638 |
| 111 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29330972 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.27922993 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.26373126 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25740141 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23356214 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22411593 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22028506 |
| 118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.15739948 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.14169048 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.10785625 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02624226 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1368435 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1313370 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1107007 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0747481 |
| 126 | Proteasome_Homo sapiens_hsa03050 | -0.0522945 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0476857 |
| 128 | DNA replication_Homo sapiens_hsa03030 | -0.0471207 |
| 129 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0188934 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0144566 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0138695 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0072691 |

